<DOC>
	<DOCNO>NCT00103454</DOCNO>
	<brief_summary>The primary objective study compare efficacy safety GW685698X 100mcg daily ( QD ) aqueous nasal spray vehicle placebo nasal spray adult adolescent subject ( 12 year age old ) perennial allergic rhinitis ( PAR ) .</brief_summary>
	<brief_title>A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis ( PAR ) .</brief_title>
	<detailed_description>A Randomized , Double-Blind , Placebo-Controlled , Parallel-Group , Multicenter Study Evaluate Efficacy Safety Once-Daily , Intranasal Administration GW685698X Aqueous Nasal Spray 100mcg 4 Weeks Adult Adolescent Subjects ( 12 year age old ) Perennial Allergic Rhinitis ( PAR )</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>Inclusion criterion : Diagnosis perennial allergic rhinitis ( PAR ) . Must comply study procedure literate . Exclusion criterion : Significant concomitant medical condition . Use corticosteroid . Use allergy medication medication study . Current tobacco use . Clinically significant abnormal ECG laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>allergic rhinitis</keyword>
	<keyword>GW685698X</keyword>
	<keyword>Perennial Allergic Rhinitis</keyword>
</DOC>